Identification of Patients at High Risk For Opioid-induced Respiratory Depression
Presented by Carla R. Jungquist, PhD, ANP-BC, FAAN, Associate Professor, University at Buffalo School of Nursing
The objective of the presentation is to provide evidence on how best to screen for patients that may experience opioid induced respiratory depression.
Primary Audience: Nurses who care for patients taking opioids either in inpatient or outpatient settings.
The goals of this presentation are:
- Establish incidence of adverse events related to opioid induced respiratory depression
- Discuss evidence based tools for screening patient’s risk for OIRD
- Report on ASPMN® Guidelines for Monitoring Hospitalized Patients for Advancing Sedation and Respiratory Depression
- Participants will demonstrate knowledge of the incidence of OIRD
- Participants will demonstrate knowledge of tools used to screen for risk of OIRD
- Participants will demonstrate knowledge of best practices for monitoring hospitalized patients for OIRD
Funding for this initiative was made possible by an educational grant from:
Carla R. Jungquist has declared the following conflict of interest: Primary Investigator of the PRODIGY Medtronic funded study. Salary support.
Dr. Jungquist has received salary support from Medtronic, Inc. for her role as University at Buffalo site primary investigator for their PRODIGY study.
Greater Kansas City Chapter of the American Society for Pain Management Nursing is approved as a provider of continuing nursing education by the Kansas State Board of Nursing. This course offering is approved for 1.2 contact hours applicable for APN, RN, LPN, LMHT relicensure. Kansas State Board of Nursing provider number LT0279-0412 GKCC. Approval valid through December 2021.